Coldstream Capital Management Inc Arrowhead Pharmaceuticals, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,380 shares of ARWR stock, worth $37,461. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,380Holding current value
$37,461% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ARWR
# of Institutions
294Shares Held
97.7MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$247 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$208 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$175 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$110 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$82.4 Million1.32% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.67B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...